NPPB and hydrops fetalis: A proposed use of biomarker-guided therapy in HF is to aggressively up-titrate medical therapy in HF, checking NT-proBNP while adjusting therapy, and the most important NT-proBNP measurement is the last one measured when medical therapy is felt to be optimized.